Catalyst
Slingshot members are tracking this event:
AstraZeneca and Astellas working with FibroGen in studies treating CKD anemia, with NDA expected in 2018
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 01, 2018
Occurred Source:
https://www.astellas.com/en/news/14291
Related Projects
Related Keywords
Nda, Ckd Anemia, Fda
